NTHL1 and breast carcinoma: For this purpose, here, we have tested the prevalence of NTHL1 p.Q90* in breast cancer patients with an indication of hereditary disease susceptibility and those unselected for the family history of cancer and age at disease onset, all collected from the North Ostrobothnia area.